Johnson & Johnson's COVID-19 vaccine has faced a number of problems this year. From manufacturing problems to alarming reports of blood clots probably related to the vaccine, it has not had the success the company probably hoped for at this point. Vaccines from Pfizer and Moderna have brought these companies much more revenue and seem to be the vaccines of choice for numerous people.
Our Analysis:
As long as the price is above 173.80, follow the recommendations below:
- Time frame: D1
- Recommendation: long position
- Entry point: 177.10
- Take Profit 1: 182.70
- Take Profit 2: 185.90
Alternative scenario:
If the level of 173.80 is broken-down, follow the recommendations below:
- Time frame: D1
- Recommendation: short position
- Entry point: 173.80
- Take Profit 1: 171.20
- Take-profit 2: 169.60
No comments:
Post a Comment